Notice of interim results

London, 8 July 2019 – Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK) will announce its interim financial results for the six months ended 30 June 2019 on Friday 09 August 2019.

Press Release Corporate 8 July 2019

A presentation and webcast for analysts will be held at 9.30am BST at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD, with registration and coffee from 9.15am.

To join via conference call please dial:

United Kingdom 0800 640 6441

United Kingdom (local) 020 3936 2999

USA 1 646 664 1960

All other locations +44 20 3936 2999

Access code: 706288

Webcast Link:

The results presentation and a webcast recording of the event will be available on the Company's website at or

A recording will be available until 10th February 2020. Please see playback details below:

UK 020 3936 3001

USA 1 845 709 8569

All other locations: +44 20 3936 3001

Access code: 732473

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.